Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2011
06/08/2011CN102089004A Pharmaceutical composition for treatment and prevention of cancer
06/08/2011CN102089001A Immunity-inducing agent and method for detection of cancer
06/08/2011CN102088999A Von willebrand factor or factor VIII and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes
06/08/2011CN102088998A Pharmaceutical compositions of somatostatin-dopamine conjugates
06/08/2011CN102088997A Compositions useful for the treatment of diabetes and other chronic disorder
06/08/2011CN102088996A Means for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory T-cells
06/08/2011CN102088995A Use of angiogenin or angiogenin agonists for treating diseases and disorders
06/08/2011CN102088994A Indoleamine 2, 3-dioxygenase based immunotherapy
06/08/2011CN102088993A Methods of treating inflammation
06/08/2011CN102088992A Peptidyl diacylglycerides
06/08/2011CN102088991A Metal abstraction peptide (MAP) tag and associated methods
06/08/2011CN102088990A Treatment for epilepsy
06/08/2011CN102088989A Glucagon analogs exhibiting enhanced solubility and stability physiological pH buffers
06/08/2011CN102088985A Intestinal environment-improving agent
06/08/2011CN102088975A Pharmaceutical compositions based on kinin B2 receptor antagonists and corticosteroids, and their use
06/08/2011CN102088872A Sialic acid to support the immune system in the elderly
06/08/2011CN102088862A Angiogenin-enriched milk fractions
06/08/2011CN102087249A Quality control method for insulin inhalation powder
06/08/2011CN102086466A Almond functional hybrid peptide and preparation method thereof
06/08/2011CN102086460A Method for producing medicinal recombinant human lysozyme
06/08/2011CN102086459A Fusion protein immunosuppressive agent and preparation method and application thereof
06/08/2011CN102086231A Fusion protein comprising ubiquitin or ubiquitin-like protein, membrane translocation sequence and biologically active molecule and use thereof
06/08/2011CN102086227A Modified peptide of human acidic fibroblast growth factor
06/08/2011CN102085377A Immunogenic composition and methods
06/08/2011CN102085371A Medical gargle product for Xerostomia and preparation method thereof
06/08/2011CN102085370A Oral spray for inflammatory diseases of oral cavity and preparation method thereof
06/08/2011CN102085369A Medical gel product for xerostomia and preparation method thereof
06/08/2011CN102085362A Polypeptide vaccine for treating diseases caused by highly pathogenic avian influenza viruses H5N1
06/08/2011CN102085361A Application of medicament containing hirudin and hementerin
06/08/2011CN102085360A Medical composition with raw materials containing hirudin and application thereof
06/08/2011CN102085359A Medical composition containing hirudin and hementerin and application thereof
06/08/2011CN102085358A Application of medicament containing hirudin, hementerin and hyaluronidase
06/08/2011CN102085357A Purpose of medicine adopting hirudin and hementerin as raw materials
06/08/2011CN102085356A Composition for increasing bone mineral density and preparation method thereof
06/08/2011CN102085355A Liraglutide long-acting microsphere injection and preparation method thereof
06/08/2011CN102085354A Polypeptide drug for treating tumors caused by human papilloma virus 16 (HPV-16)
06/08/2011CN102085353A Polypeptide drug for treating tumors caused by human papilloma virus 18 (HPV-18)
06/08/2011CN102085217A Pharmaceutical composition containing medicinal calcium salt for early preventing colorectal adenoma or colorectal cancer
06/08/2011CN101637457B Preparation method for cerebroprotein hydrolysate freeze-dried injection for injection
06/08/2011CN101456913B Anti-tumor fusion protein and use thereof
06/08/2011CN101444486B Water-soluble drug sustained-release microsphere and preparation method and applications thereof
06/08/2011CN101391101B New use of cyclodextrin glucanotransferase
06/08/2011CN101385858B Purified PEG human growth hormone conjugates and preparation thereof
06/08/2011CN101139613B Antineoplastic dibasic polypeptide and application and preparation method thereof
06/07/2011US7956176 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
06/07/2011US7956166 separationof proteins from milk, vegetables, fish or fruits, by adjusting the pH of the mixture, then applying the mixture to an adsorption column comprising an adsorbent particles having a high density non-porous core surrounded by porous materials, washing the column and eluting at least one protein
06/07/2011US7956162 Cancer-associated antigen
06/07/2011US7956161 Interferons of rhesus and cynomolgus origin and uses thereof
06/07/2011US7956160 Freeze dried protein composition comprising manitol polymorphs which reconstitute quickly upon addition of diluent and provide solutions of high protein concentrations, with reduced formation of foam, effervescence, bubbles, aggregates and particulates
06/07/2011US7956158 Fusion proteins with cleavable spacers and uses thereof
06/07/2011US7956081 Isolating preferential protein from tissue extract using acidic washes and centrifugation
06/07/2011US7956041 Prophylactic and therapeutic agent of diabetes mellitus
06/07/2011US7956038 GASP1: a follistatin domain containing protein
06/07/2011US7956037 Cytoprotective therapeutic agents for the prevention of reperfusion injury following ischemic stroke
06/07/2011US7956036 Polypeptide and DNA thereof useful as a neovascular marker
06/07/2011US7956035 Administering high density lipoprotein
06/07/2011US7956034 FSH mutant with increased glycosylation and longer half-life; for inducing folliculogenesis in human; treating an infertile mammal
06/07/2011US7956033 Modified peptide of human acidic fibroblast growth factor
06/07/2011US7956032 Glycopegylated granulocyte colony stimulating factor
06/07/2011US7956031 Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
06/07/2011US7956030 Method for reducing pain with ziconotide and baclofen
06/07/2011US7956028 Protein stabilization formulations
06/07/2011US7955845 Transgenic cells comprising enhanced immune response for use in treatment of infections, cancers and pathologies associated with transplantation
06/07/2011US7955844 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
06/07/2011US7955808 Bitter taste receptors
06/07/2011US7955614 Microfabricated nanopore device for sustained release of therapeutic agent
06/07/2011US7955595 Glutamic acid decarboxylase (GAD) based delivery system
06/07/2011US7955590 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
06/07/2011CA2506157C Treatment of diabetes
06/07/2011CA2471144C Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
06/07/2011CA2470515C Dna minor groove binding compounds
06/07/2011CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
06/07/2011CA2442971C Chemotherapeutic induction of egr-1 promoter activity
06/07/2011CA2442194C Novel peptide sy
06/07/2011CA2438787C Virus derived antimicrobial peptides
06/07/2011CA2424483C Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes
06/07/2011CA2423190C Angiogenic agents and their uses
06/07/2011CA2418422C Novel kallikrein gene
06/07/2011CA2405705C The treatment of respiratory diseases
06/07/2011CA2404431C Guanylyl cyclase c in the detection of stomach and esophageal cancers
06/07/2011CA2402578C Method for surface treatment of implants or prosthesis made of titanium or other materials
06/07/2011CA2378866C Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
06/07/2011CA2377627C Cartilage enhancing food supplements and methods of preparing the same
06/07/2011CA2306216C The use of inhibitors of the renin-angiotensin system for the treatment of cachexia and wasting
06/07/2011CA2230556C Novel procollagens
06/07/2011CA2187083C Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
06/03/2011WO2011066521A2 Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
06/03/2011WO2011066511A1 Synthetic apoa-1 mimetic amphipathic peptides and methods of use thereof
06/03/2011WO2011066453A2 Pacap and related proteins in the treatment of cancer
06/03/2011WO2011066378A2 Antagonists of il-6 to prevent or treat thrombosis
06/03/2011WO2011066374A2 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
06/03/2011WO2011066372A2 Citrullination of human peptidylarginine deiminase 4 (pad-4) regulates its function and immunogenicity
06/03/2011WO2011066371A2 Antibodies to il-6 and use thereof
06/03/2011WO2011066369A2 Antagonists of il-6 to raise albumin and/or lower crp
06/03/2011WO2011066316A2 Treating neoplasms with neurotoxin
06/03/2011WO2011066285A2 Peptide-based treatment for neurodegenerative diseases
06/03/2011WO2011066282A2 Methods and compositions for treating oxalate-related conditions
06/03/2011WO2011066260A2 Formulations comprising aminosterols
06/03/2011WO2011066182A2 Socs3 inhibition promotes cns neuron regeneration
06/03/2011WO2011065982A2 Polymorphisms associated with parkinson's disease